Poniard Pharmaceuticals Inc (PARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2010 | 12-2009 | 12-2008 | 12-2007 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | N/A | 1,440 | 16,210 | N/A | 29,610 |
| Marketable Securities | N/A | 3,040 | 27,450 | N/A | 63,280 |
| Other current assets | 0 | 730 | 830 | 970 | 960 |
| TOTAL | $N/A | $5,210 | $44,490 | $970 | $93,850 |
| Non-Current Assets | |||||
| PPE Net | N/A | 40 | 210 | 1,130 | 1,120 |
| Other Non-Current Assets | 0 | 6,370 | 7,720 | 9,080 | 10,160 |
| TOTAL | $N/A | $6,410 | $7,930 | $10,210 | $11,280 |
| Total Assets | $N/A | $11,640 | $52,440 | $11,180 | $105,140 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 0 | 390 | 840 | 600 | 670 |
| Accrued Expenses | N/A | 1,220 | 7,670 | 10,610 | 4,550 |
| TOTAL | $N/A | $1,610 | $17,120 | $19,120 | $9,470 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 0 | 10,180 | N/A | 6,560 |
| TOTAL | $N/A | $1,570 | $11,660 | $N/A | $6,560 |
| Total Liabilities | $N/A | $3,190 | $28,790 | $19,120 | $16,030 |
| Shareholders' Equity | |||||
| Common Shares | N/A | 970 | 840 | 690 | 690 |
| Retained earnings | N/A | -438,940 | -408,150 | N/A | -312,810 |
| Other shareholders' equity | 0 | 10 | -20 | 0 | 0 |
| TOTAL | $N/A | $8,450 | $23,640 | $409,930 | $89,100 |
| Total Liabilities And Equity | $0 | $11,640 | $52,430 | $429,050 | $105,130 |